← Back to all media
Tough year for International Biotechnology but confidence remains
Tough year for International Biotechnology but confidence remains – International Biotechnology (IBT) has published its annual results for the year to 31 August 2021. During this time, the company’s NAV per share and share price returned 9.8% and 3.8% respectively whilst the Nasdaq Biotechnology Index returned 22.8%. The board said while this is a disappointing outcome, there has been a short-term factor impacting relative performance and it remains confident IBT will outperform in the future.
Published on 1st November 2021